患有急性失偿心力衰竭的患者内源性氧化产量下降,并保留了喷射分数
Roman Falls1, Bing H Wang2, Sara Vogrin3
1School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC 3083, Australia.
Journal of clinical medicine
|September 13, 2025
概括
患有急性心力衰竭和保留喷射分数 (HFpEF) 的患者表现出较低的血亚酸盐水平,这表明氧化的产生受损. 这一发现突显了HFpEF患者急性脱补偿期间氧化途径的潜在失调.
科学领域:
- 心脏病学 心脏病学
- 生物化学 生物化学
- 生理学 生理学 生理学
背景情况:
- 保存喷射分数 (HFpEF) 的心力衰竭影响50%的心力衰竭患者.
- 内皮功能障碍和氧化物 (NO) 生产受损与HFpEF脱补偿有关.
- 血亚酸盐 (NO2-) 反映了当地的NO生产,但其在急性和慢性HFpEF中的水平尚未研究.
研究的目的:
- 调查慢性与急性HFpEF患者的酸盐 (NO2-) 和酸盐 (NO3-) 血水平.
- 评估NO2-水平与内皮功能障碍标志物 (如ADMA和动脉硬) 在HFpEF中的关系.
主要方法:
- 使用气相化学发光的量化血NO2和NO3.
- 测量了血不对称二甲基氨基 (ADMA) 和动脉硬度指数.
- 从19名慢性HFpEF和16名急性HFpEF参与者收集了样本.
主要成果:
- 与慢性HFpEF组相比,急性HFpEF组的血NO2-度明显较低 (p = 0.022).
- 两组之间在血NO3,ADMA或动脉硬度方面没有发现显著差异.
结论:
- 这项研究提供了关于急性HFpEF中的血NO2-的新数据.
- 低血NO2-在急性HFpEF中表明在去补偿期间有失调的氧化路径.
- 需要进一步的研究来验证这些发现在更大的HFpEF群体中.
相关概念视频
Nitric Oxide Signaling Pathway
6.2K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.2K
Heart Failure V: Medical Management
223
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
223
Heart Failure II: Pathophysiology
734
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
734
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
942
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
942
Antianginal Drugs: Nitrates and β-Blockers
1.4K
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.4K
Heart Failure VII: Nursing Interventions
422
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
422


